Levi Garraway, Roche's chief medical officer and head of global product development. Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
Use these 7 Microsoft promo codes to save on computer software, PCs, laptops and more. All coupon content is created by PC Gamer. We may earn a commission if you buy through our links. More Info.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback